S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.19 (+0.98%)
AAPL   116.48 (+0.39%)
MSFT   215.19 (+0.62%)
FB   277.73 (+0.78%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,196.00 (+0.34%)
TSLA   585.75 (+2.05%)
NVDA   530.40 (+0.19%)
BABA   276.50 (-0.44%)
CGC   29.14 (+8.45%)
GE   10.40 (-0.95%)
MU   64.21 (+1.23%)
AMD   87.17 (+0.53%)
T   29.03 (+0.14%)
NIO   53.88 (+0.35%)
F   9.10 (+0.22%)
ACB   10.76 (+23.54%)
NFLX   490.53 (+1.14%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.19 (+0.98%)
AAPL   116.48 (+0.39%)
MSFT   215.19 (+0.62%)
FB   277.73 (+0.78%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,196.00 (+0.34%)
TSLA   585.75 (+2.05%)
NVDA   530.40 (+0.19%)
BABA   276.50 (-0.44%)
CGC   29.14 (+8.45%)
GE   10.40 (-0.95%)
MU   64.21 (+1.23%)
AMD   87.17 (+0.53%)
T   29.03 (+0.14%)
NIO   53.88 (+0.35%)
F   9.10 (+0.22%)
ACB   10.76 (+23.54%)
NFLX   490.53 (+1.14%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.19 (+0.98%)
AAPL   116.48 (+0.39%)
MSFT   215.19 (+0.62%)
FB   277.73 (+0.78%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,196.00 (+0.34%)
TSLA   585.75 (+2.05%)
NVDA   530.40 (+0.19%)
BABA   276.50 (-0.44%)
CGC   29.14 (+8.45%)
GE   10.40 (-0.95%)
MU   64.21 (+1.23%)
AMD   87.17 (+0.53%)
T   29.03 (+0.14%)
NIO   53.88 (+0.35%)
F   9.10 (+0.22%)
ACB   10.76 (+23.54%)
NFLX   490.53 (+1.14%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.19 (+0.98%)
AAPL   116.48 (+0.39%)
MSFT   215.19 (+0.62%)
FB   277.73 (+0.78%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,196.00 (+0.34%)
TSLA   585.75 (+2.05%)
NVDA   530.40 (+0.19%)
BABA   276.50 (-0.44%)
CGC   29.14 (+8.45%)
GE   10.40 (-0.95%)
MU   64.21 (+1.23%)
AMD   87.17 (+0.53%)
T   29.03 (+0.14%)
NIO   53.88 (+0.35%)
F   9.10 (+0.22%)
ACB   10.76 (+23.54%)
NFLX   490.53 (+1.14%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
Log in
OTCMKTS:MMNFF

MedMen Enterprises Stock Forecast, Price & News

$0.14
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.13
Now: $0.14
$0.15
50-Day Range
$0.11
MA: $0.13
$0.17
52-Week Range
$0.09
Now: $0.14
$0.76
Volume5.49 million shs
Average Volume2.53 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. The company was founded in 2010 and is headquartered in Culver City, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MMNFF
CUSIPN/A
CIKN/A
Phone855-292-8399
Employees1,000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.14
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMNFF News and Ratings via Email

Sign-up to receive the latest news and ratings for MMNFF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedMen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions

How has MedMen Enterprises' stock been impacted by COVID-19?

MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMNFF stock has decreased by 10.0% and is now trading at $0.1385.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of MedMen Enterprises?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for MedMen Enterprises
.

What stocks does MarketBeat like better than MedMen Enterprises?

Wall Street analysts have given MedMen Enterprises a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedMen Enterprises wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What guidance has MedMen Enterprises issued on next quarter's earnings?

MedMen Enterprises issued an update on its first quarter 2021 After-Hours earnings guidance on Friday, October, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $60.245-60.245 million.

What price target have analysts set for MMNFF?

4 Wall Street analysts have issued 12 month price objectives for MedMen Enterprises' stock. Their forecasts range from $0.75 to $4.00. On average, they expect MedMen Enterprises' stock price to reach $2.38 in the next year. This suggests a possible upside of 1,614.8% from the stock's current price.
View analysts' price targets for MedMen Enterprises
.

Are investors shorting MedMen Enterprises?

MedMen Enterprises saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 5,748,000 shares, an increase of 22.1% from the September 30th total of 4,706,500 shares. Based on an average daily trading volume, of 6,756,900 shares, the short-interest ratio is currently 0.9 days.
View MedMen Enterprises' Short Interest
.

Who are some of MedMen Enterprises' key competitors?

Who are MedMen Enterprises' key executives?

MedMen Enterprises' management team includes the following people:
  • Mr. Benjamin Rose, Exec. Chairman (Age 46, Pay $62.5k)
  • Mr. Adam Nathaniel Bierman, Co-Founder (Age 39, Pay $1.15M)
  • Mr. Zeeshan Hyder, Chief Financial Officer (Age 33, Pay $541.56k)
  • Mr. Michael Jay Lane, Chief Information Officer (Age 49, Pay $253.72k)
  • Mr. Thomas Jerome Lynch, Interim CEO & Chief Restructuring Officer (Age 52)
  • Mr. Timothy Bossidy, Interim Chief Operating Officer (Age 32)
  • Ms. Stéphanie Van Hassel, VP of Investor Relations
  • Mr. Dan Edwards, Sr. VP of Legal Affairs
  • Christian Langbein, VP of Communications
  • Ms. Esther Song, Sr. VP of Marketing & Communications

What is MedMen Enterprises' stock symbol?

MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."

How do I buy shares of MedMen Enterprises?

Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MedMen Enterprises' stock price today?

One share of MMNFF stock can currently be purchased for approximately $0.14.

What is MedMen Enterprises' official website?

The official website for MedMen Enterprises is www.medmen.com.

How can I contact MedMen Enterprises?

The company can be reached via phone at 855-292-8399.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.